Kajian klinikal Epilepsi di Missouri
8 kajian untuk Epilepsi sedang mencari peserta di lokasi di Missouri.
Bandar di Missouri
Teks kajian rasmi (Bahasa Inggeris)
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
- Washington University -- St. Louis, St Louis
Mengambil pesertaFasa 2
1 Day – 6 Months · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05104983Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
- Washington University, St Louis
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 75 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07110454Diagnosing Epilepsy To EffeCT Change
- Washington University, St Louis
Mengambil peserta
Umur 18 hingga 75 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07110337A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Saint Louis University Medical School, St Louis
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT05667142Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
- St. Louis Children's Hospital, St Louis
Mengambil pesertaKajian pemerhatian
Sehingga umur 26 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT05374824Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Washington University at St. Louis, St Louis
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 9 Jun 2026 · NCT05135091Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
- University of Missouri - Columbia, Columbia
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Sehingga umur 99 · Semua jantina · Dikemas kini 9 Jan 2026 · NCT07329257Amygdala Memory Enhancement
- Washington University School of Medicine, St Louis
Mengambil peserta
Umur 18 hingga 75 · Semua jantina · Dikemas kini 17 Jul 2025 · NCT05065450Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.